The table below summarizes the most recent Bioanalytical Systems insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Bioanalytical Systems insider buys are important for investors to follow.

Date	Insider	Price	Amount
2-23-2021 Insider Buy	John Gregory Beattie Chief Operating Officer	$14.00 CAGR »	$116,032.00 8,288 shares
2-24-2021 Insider Buy	Robert Leasure Jr. President and CEO	$14.42 CAGR »	$72,100.00 5,000 shares
3-5-2021 Insider Buy	Beth Taylor VP- Finance & CFO	$17.70 CAGR »	$88,500.00 5,000 shares
3-1-2021 Insider Buy	John Gregory Beattie Chief Operating Officer	$18.60 CAGR »	$31,843.20 1,712 shares
2-20-2020 Insider Buy	R. Matthew Neff Director	$4.60 CAGR »	$43,506.80 9,458 shares
8-19-2020 Insider Buy	John E. Sagartz Chief Strategy Officer	$4.75 CAGR »	$17,731.75 3,733 shares
6-15-2020 Insider Buy	Robert Leasure Jr. President and CEO	$5.20 CAGR »	$14,996.80 2,884 shares
5-21-2020 Insider Buy	Beth Taylor VP- Finance & CFO	$4.43 CAGR »	$58,913.32 13,300 shares
9-13-2019 Insider Buy	William D. Pitchford Chief HR Officer	$3.70 CAGR »	$44,400.00 12,000 shares
9-13-2019 Insider Buy	Daniel Thomas Oakley Chief Operating Officer	$3.65 CAGR »	$3,650.00 1,000 shares
9-13-2019 Insider Buy	Robert Leasure Jr. President and CEO	$3.72 CAGR »	$99,867.12 26,846 shares
9-6-2019 Insider Buy	Daniel Thomas Oakley Chief Operating Officer	$3.43 CAGR »	$42,925.00 12,500 shares
9-4-2019 Insider Buy	Robert Leasure Jr. President and CEO	$3.15 CAGR »	$36,225.00 11,500 shares
8-19-2019 Insider Buy	Robert Leasure Jr. President and CEO	$2.19 CAGR »	$35,040.00 16,000 shares
6-14-2019 Insider Buy	Daniel Thomas Oakley Chief Operating Officer	$1.99 CAGR »	$14,925.00 7,500 shares
6-13-2019 Insider Buy	Robert Leasure Jr. President and CEO	$1.97 CAGR »	$9,857.76 5,004 shares
6-11-2019 Insider Buy	Jill Blumhoff VP, Finance & CFO	$1.98 CAGR »	$990.00 500 shares
6-10-2019 Insider Buy	Philip A. Downing Sr. VP, Preclinical Srvcs.	$1.96 CAGR »	$9,800.00 5,000 shares
3-12-2019 Insider Buy	Robert Leasure Jr. President and CEO	$1.94 CAGR »	$11,640.00 6,000 shares
3-8-2019 Insider Buy	R. Matthew Neff Director	$1.75 CAGR »	$10,001.25 5,715 shares
3-8-2019 Insider Buy	Robert Leasure Jr. President and CEO	$1.77 CAGR »	$7,080.00 4,000 shares
3-1-2019 Insider Buy	Robert Leasure Jr. President and CEO	$1.57 CAGR »	$29,639.00 18,900 shares
9-14-2018 Insider Buy	Peter Kissinger >10% Owner	$1.74 CAGR »	$17,382.00 10,000 shares
9-14-2018 Insider Buy	R. Matthew Neff Director	$1.66 CAGR »	$4,150.00 2,500 shares
9-8-2017 Insider Buy	R. Matthew Neff Director	$1.50 CAGR »	$7,500.00 5,000 shares
8-18-2017 Insider Buy	R. Matthew Neff Director	$1.70 CAGR »	$8,500.00 5,000 shares
8-18-2017 Insider Buy	Gregory Cole Davis Director	$1.70 CAGR »	$8,500.00 5,000 shares
5-27-2016 Insider Buy	Connie Leigh Dougherty VP, Business Development	$0.92 CAGR »	$389.16 423 shares
5-23-2016 Insider Buy	Connie Leigh Dougherty VP, Business Development	$0.92 CAGR »	$88.32 96 shares
5-19-2016 Insider Buy	Connie Leigh Dougherty VP, Business Development	$0.92 CAGR »	$1,522.60 1,655 shares
2-29-2016 Insider Buy	Jacqueline M. Lemke President and CEO	$1.18 CAGR »	$11,761.60 10,000 shares
9-14-2015 Insider Buy	Philip A. Downing VP, Preclinical Srvcs.	$1.73 CAGR »	$5,190.00 3,000 shares
8-21-2015 Insider Buy	Connie Leigh Dougherty VP, Business Development	$1.42 CAGR »	$9,798.00 6,900 shares
2-27-2015 Insider Buy	Jacqueline M. Lemke President and CEO	$2.04 CAGR »	$20,400.00 10,000 shares
8-17-2012 Insider Buy	David L. Omachinski Director	$1.26 CAGR »	$12,600.00 10,000 shares
8-17-2012 Insider Buy	Larry Steven Boulet Director	$1.26 CAGR »	$14,490.00 11,500 shares
8-17-2012 Insider Buy	John B. Landis Director	$1.26 CAGR »	$37,800.00 30,000 shares
8-17-2012 Insider Buy	David W. Crabb Director	$1.26 CAGR »	$12,600.00 10,000 shares
8-17-2012 Insider Buy	Jacqueline M. Lemke Intrm Pres & CEO, CFO & VP Fin	$1.26 CAGR »	$25,200.00 20,000 shares
8-17-2012 Insider Buy	A. Charlene Sullivan Director	$1.26 CAGR »	$12,600.00 10,000 shares
8-17-2012 Insider Buy	Richard Allen Johnson Director	$1.26 CAGR »	$12,600.00 10,000 shares

Also See: Institutional Holders of BASI
Also See: SEC filings

Below we present the annualized performance delivered by Bioanalytical Systems stock since 2-23-2021 (the date of the most recent insider purchase). The performance of the investment from the time Bioanalytical Systems insider buying occurred is the ultimate test of whether insiders were right about BASI being a good buy.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	02/24/2021
End date:	03/19/2021
Start price/share:	$14.64
End price/share:	$16.44
Dividends collected/share:	$0.00
Total return:	12.30%
Annualized Gain:	203.99%
Starting investment:	$10,000.00
Ending investment:	$11,230.00
Years:	0.06

Bioanalytical Systems Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Bioanalytical Systems insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding BASI

BASI — Current Quote

Quotes delayed 20 minutes

Free BASI Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

BASI — Performance

Bioanalytical Systems Insider Buying

Bioanalytical Systems Insider Buying | www.HoldingsChannel.com